Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 557,410 |
Total Actual Volume | 10,397,267 |
Short Trends | |
---|---|
Cover Days | 2 |
Short Days | 8 |
No Change Days | 10 |
Averages | |
---|---|
Average Short Volume | 27,871 |
Average Short Percentage | 48.46% |
Is there a BTX Short Squeeze or Breakout about to happen?
See the BTX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2021-10-22 | 9.59 | 9.01 | 9.6 | 8.7 | 880,740 | 43,903 | 70.2774 |
2021-10-21 | 9.76 | 9.62 | 10.1 | 9.6 | 441,734 | 11,906 | 31.1733 |
2021-10-20 | 9.47 | 9.73 | 9.75 | 9.16 | 439,424 | 37,259 | 47.5449 |
2021-10-19 | 9.25 | 9.38 | 9.59 | 9.1742 | 304,121 | 7,088 | 19.3756 |
2021-10-18 | 9.09 | 9.29 | 9.34 | 9.0306 | 266,223 | 16,911 | 51.8663 |
2021-10-15 | 9.45 | 9.15 | 9.45 | 9.04 | 418,401 | 7,847 | 39.2232 |
2021-10-14 | 9.29 | 9.12 | 9.4699 | 9.08 | 277,607 | 12,561 | 38.0625 |
2021-10-13 | 9 | 9.23 | 9.29 | 8.82 | 468,248 | 26,834 | 55.7335 |
2021-10-12 | 8.44 | 9.06 | 9.085 | 8.44 | 944,961 | 40,862 | 37.9135 |
2021-10-11 | 8.29 | 8.5 | 8.67 | 8.25 | 536,101 | 25,213 | 40.0149 |
2021-10-08 | 8.9 | 8.32 | 8.99 | 8.25 | 710,585 | 74,220 | 68.0549 |
2021-10-07 | 8.67 | 8.67 | 9.47 | 8.5801 | 830,268 | 64,564 | 43.6364 |
2021-10-06 | 9.16 | 8.64 | 9.2399 | 8.49 | 577,568 | 44,992 | 61.4024 |
2021-10-05 | 9.03 | 9.01 | 9.18 | 8.91 | 393,242 | 10,798 | 36.6295 |
2021-10-04 | 9.06 | 8.99 | 9.2598 | 8.86 | 390,012 | 28,417 | 76.4268 |
2021-10-01 | 9.29 | 9.14 | 9.3469 | 8.95 | 365,664 | 20,730 | 65.8597 |
2021-09-30 | 9.05 | 9.3 | 9.67 | 8.95 | 689,024 | 16,917 | 35.7298 |
2021-09-29 | 9.59 | 9.14 | 9.59 | 9.08 | 408,049 | 15,879 | 48.5092 |
2021-09-28 | 9.29 | 9.36 | 9.61 | 9.24 | 456,036 | 20,440 | 44.6220 |
2021-09-27 | 9.43 | 9.52 | 9.87 | 9.42 | 599,259 | 30,069 | 57.0743 |
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused on developing advanced therapies using state-of-the-art mRNA cell engineering technology, today ann...
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have on the immune system f...
SAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc . (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have on the immune system fo...